Biobanking and international interoperability: samples

How Unbiased is Non-Targeted Metabolomics and is Targeted Pathway Screening the Solution?

(2011) Uwe Christians et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Characterization of Differences between Blood Sample Matrices in Untargeted Metabolomics

(2010) Judith R. Denery et al.   ANALYTICAL CHEMISTRY

International Efforts to Develop Biospecimen Best Practices

(2010) J. B. Vaught et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Standard Preanalytical Coding for Biospecimens: Defining the Sample PREanalytical Code

(2010) F. Betsou et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Biobanking: the foundation of personalized medicine

(2010) Robert E Hewitt   CURRENT OPINION IN ONCOLOGY

Analytical Recovery of Folate and Its Degradation Products in Human Serum Stored at −25°C for up to 29 Years

(2010) Rita Hannisdal et al.   JOURNAL OF NUTRITION

Progressive degradation of serum samples limits proteomic biomarker discovery

(2009) Shadab Ahmad et al.   ANALYTICAL BIOCHEMISTRY

The UK DNA banking network: a “fair access” biobank

(2009) Martin Yuille et al.   CELL AND TISSUE BANKING

Legal and ethical consequences of international biobanking from a national perspective: the German BMB-EUCoop project

(2009) Jürgen W Goebel et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Sources of Bias in Specimens for Research About Molecular Markers for Cancer

(2009) David F. Ransohoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum

(2008) Juliette Lengellé et al.   CYTOKINE

Banking together. A unified model of informed consent for biobanking

(2008) Elena Salvaterra et al.   EMBO REPORTS